Compare FENC & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | TSSI |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | United States | United States |
| Employees | N/A | 161 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 315.9M |
| IPO Year | 2010 | N/A |
| Metric | FENC | TSSI |
|---|---|---|
| Price | $6.50 | $14.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $14.50 | ★ $16.00 |
| AVG Volume (30 Days) | 133.5K | ★ 1.5M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | $3.67 |
| P/E Ratio | ★ N/A | $42.71 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $6.67 |
| 52 Week High | $9.92 | $31.94 |
| Indicator | FENC | TSSI |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 55.72 |
| Support Level | $5.65 | $13.97 |
| Resistance Level | $8.09 | $16.42 |
| Average True Range (ATR) | 0.34 | 1.22 |
| MACD | 0.04 | -0.13 |
| Stochastic Oscillator | 48.51 | 42.09 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.